SHIM
PLSE icon

Stone House Investment Management’s Pulse Biosciences PLSE Stock Holding History

Stone House Investment Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$691 Hold
32
– – ﹤0.01% 761
2025
Q4 		$439 Buy
+32
New +$499 ﹤0.01% 733

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Stone House Investment Management's PLSE Position: Q1 2026 in Review

Stone House Investment Management held its Pulse Biosciences (PLSE) position steady in Q1 2026 at 32 shares worth $691. The position accounts for ﹤0.01% of the portfolio, ranked #761.

Stone House Investment Management first reported a position in PLSE in Q4 2025 and has held it in 2 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Stone House Investment Management held 32 shares of Pulse Biosciences worth $691 as of Q1 2026.
  • Stone House Investment Management left its Pulse Biosciences share count unchanged in Q1 2026.
  • Pulse Biosciences made up ﹤0.01% of Stone House Investment Management's portfolio in Q1 2026, its #761 holding.
  • Stone House Investment Management first reported a position in Pulse Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.